These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 18505909)

  • 21. Long-term survival over 28 years of a patient with metastatic adrenal cortical carcinoma--case report.
    Meyer A; Behrend M
    Anticancer Res; 2004; 24(3b):1901-4. PubMed ID: 15274373
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of adrenal cortical carcinoma with mitotane: outcome and complications.
    Lim MC; Tan YO; Chong PY; Cheah JS
    Ann Acad Med Singap; 1990 Jul; 19(4):540-4. PubMed ID: 2171414
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Brain metastasis in patients with adrenocortical carcinoma: a clinical series.
    Burotto M; Tageja N; Rosenberg A; Mahalingam S; Quezado M; Velarde M; Edgerly M; Fojo T
    J Clin Endocrinol Metab; 2015 Feb; 100(2):331-6. PubMed ID: 25412413
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metastatic adrenocortical carcinoma treated by repeated resection: a case report of long-term survival over 18 years.
    Sakamoto K; Ariyoshi A; Okazaki M
    Int J Urol; 1995 Mar; 2(1):50-2. PubMed ID: 7614407
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term disease free survival in a patient with metastatic adreno-cortical carcinoma after complete pathological response to chemotherapy plus mitotane.
    Sperone P; Berruti A; Gorzegno G; Paccotti P; Terzolo M; Porpiglia F; Angeli A; Dogliotti L
    J Endocrinol Invest; 2006 Jun; 29(6):560-2. PubMed ID: 16840836
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A phase II trial of combination chemotherapy and surgical resection for the treatment of metastatic adrenocortical carcinoma: continuous infusion doxorubicin, vincristine, and etoposide with daily mitotane as a P-glycoprotein antagonist.
    Abraham J; Bakke S; Rutt A; Meadows B; Merino M; Alexander R; Schrump D; Bartlett D; Choyke P; Robey R; Hung E; Steinberg SM; Bates S; Fojo T
    Cancer; 2002 May; 94(9):2333-43. PubMed ID: 12015757
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mitotane levels predict the outcome of patients with adrenocortical carcinoma treated adjuvantly following radical resection.
    Terzolo M; Baudin AE; Ardito A; Kroiss M; Leboulleux S; Daffara F; Perotti P; Feelders RA; deVries JH; Zaggia B; De Francia S; Volante M; Haak HR; Allolio B; Al Ghuzlan A; Fassnacht M; Berruti A
    Eur J Endocrinol; 2013 Sep; 169(3):263-70. PubMed ID: 23704714
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Resection of adrenocortical carcinoma liver metastasis: is it justified?
    Gaujoux S; Al-Ahmadie H; Allen PJ; Gonen M; Shia J; D'Angelica M; Dematteo R; Fong Y; Blumgart L; Jarnagin WR
    Ann Surg Oncol; 2012 Aug; 19(8):2643-51. PubMed ID: 22526905
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Laparoscopic resection of adrenal cortical carcinoma: a cautionary note.
    Gonzalez RJ; Shapiro S; Sarlis N; Vassilopoulou-Sellin R; Perrier ND; Evans DB; Lee JE
    Surgery; 2005 Dec; 138(6):1078-85; discussion 1085-6. PubMed ID: 16360394
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improved survival in patients with stage II adrenocortical carcinoma followed up prospectively by specialized centers.
    Fassnacht M; Johanssen S; Fenske W; Weismann D; Agha A; Beuschlein F; Führer D; Jurowich C; Quinkler M; Petersenn S; Spahn M; Hahner S; Allolio B;
    J Clin Endocrinol Metab; 2010 Nov; 95(11):4925-32. PubMed ID: 20668036
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Cancer of the adrenal cortex treated by O,P"-DDD (author's transl)].
    Van Geertruyden J; De Myttenaere M; Corvilain J
    Acta Chir Belg; 1980; 79(4):299-302. PubMed ID: 7468032
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adjuvant radiation therapy improves local control after surgical resection in patients with localized adrenocortical carcinoma.
    Sabolch A; Else T; Griffith KA; Ben-Josef E; Williams A; Miller BS; Worden F; Hammer GD; Jolly S
    Int J Radiat Oncol Biol Phys; 2015 Jun; 92(2):252-9. PubMed ID: 25754631
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The treatment of adrenocortical carcinoma with o,p'-DDD: prognostic implications of serum level monitoring.
    van Slooten H; Moolenaar AJ; van Seters AP; Smeenk D
    Eur J Cancer Clin Oncol; 1984 Jan; 20(1):47-53. PubMed ID: 6537915
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pediatric adrenal cortical carcinoma: brain metastases and relationship to NF-1, case reports and review of the literature.
    Wagner AS; Fleitz JM; Kleinschmidt-Demasters BK
    J Neurooncol; 2005 Nov; 75(2):127-33. PubMed ID: 16132517
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Approach to the patient with adrenocortical carcinoma.
    Lacroix A
    J Clin Endocrinol Metab; 2010 Nov; 95(11):4812-22. PubMed ID: 21051577
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chiral effects in adrenocorticolytic action of o,p'-DDD (mitotane) in human adrenal cells.
    Asp V; Cantillana T; Bergman A; Brandt I
    Xenobiotica; 2010 Mar; 40(3):177-83. PubMed ID: 20044879
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of lymphadenectomy on the oncologic outcome of patients with adrenocortical carcinoma.
    Reibetanz J; Jurowich C; Erdogan I; Nies C; Rayes N; Dralle H; Behrend M; Allolio B; Fassnacht M;
    Ann Surg; 2012 Feb; 255(2):363-9. PubMed ID: 22143204
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical role of determination of plasma mitotane and its metabolites levels in patients with adrenal cancer: results of a long-term follow-up.
    Kasperlik-Zaluska AA; Cichocki A
    J Exp Ther Oncol; 2005; 5(2):125-32. PubMed ID: 16471038
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lipoprotein-Free Mitotane Exerts High Cytotoxic Activity in Adrenocortical Carcinoma.
    Hescot S; Seck A; Guerin M; Cockenpot F; Huby T; Broutin S; Young J; Paci A; Baudin E; Lombès M
    J Clin Endocrinol Metab; 2015 Aug; 100(8):2890-8. PubMed ID: 26120791
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.